Cargando…

Alveolar soft part sarcoma of the right calf: A case report

RATIONALE: Alveolar soft part sarcoma (ASPS) is a rare malignant soft tissue neoplasm with controversial histogenesis. ASPS accounts for 0.5% to 1% of all soft tissue sarcomas. Because of its rarity, ASPS is easily misdiagnosed, increasing the risk of incorrect treatment. PATIENT CONCERNS: A 6-year-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bin, Wang, Huanhuan, Wei, Jinlong, Qu, Limei, Meng, Lingbin, Xin, Ying, Jiang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004695/
https://www.ncbi.nlm.nih.gov/pubmed/32000418
http://dx.doi.org/10.1097/MD.0000000000018952
_version_ 1783494781309026304
author Wang, Bin
Wang, Huanhuan
Wei, Jinlong
Qu, Limei
Meng, Lingbin
Xin, Ying
Jiang, Xin
author_facet Wang, Bin
Wang, Huanhuan
Wei, Jinlong
Qu, Limei
Meng, Lingbin
Xin, Ying
Jiang, Xin
author_sort Wang, Bin
collection PubMed
description RATIONALE: Alveolar soft part sarcoma (ASPS) is a rare malignant soft tissue neoplasm with controversial histogenesis. ASPS accounts for 0.5% to 1% of all soft tissue sarcomas. Because of its rarity, ASPS is easily misdiagnosed, increasing the risk of incorrect treatment. PATIENT CONCERNS: A 6-year-old female patient presented with a history of a 2.0 × 2.5 × 3.0-cm mass in the deep soft tissues of her right lower extremity. DIAGNOSES: Histopathological features indicated the diagnosis of ASPS. Microscopically, a diffuse arrangement of tumor cells or pseudoalveolar architectures separated by thin and well-vascularized fibrous septa were observed. Immunohistochemical staining of the tumor cells indicated positivity for transcription factor E3, myogenic determination factor 1, and periodic acid–Schiff–diastase (PAS-D) and showed a Ki-67 proliferating index of approximately 20%. INTERVENTIONS: The patient underwent enlarged resection of the tumor and was treated with radiotherapy. OUTCOMES: During the 3-year follow-up, the patient has remained in good condition, with no symptom recurrence, distant metastatic spread, or significant toxicity during or after treatment. The patient remains under regular surveillance. LESSONS: Its low incidence, lack of characteristic clinical manifestations, and atypical location often lead to ASPS misdiagnosis and subsequent incorrect treatment. Nuclear expression of transcription factor E3 is of diagnostic value for ASPS. At present, there is no consensus on the treatment for ASPS. In-depth pathological analysis is needed to better understand the characteristics of this tumor.
format Online
Article
Text
id pubmed-7004695
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-70046952020-02-18 Alveolar soft part sarcoma of the right calf: A case report Wang, Bin Wang, Huanhuan Wei, Jinlong Qu, Limei Meng, Lingbin Xin, Ying Jiang, Xin Medicine (Baltimore) 5700 RATIONALE: Alveolar soft part sarcoma (ASPS) is a rare malignant soft tissue neoplasm with controversial histogenesis. ASPS accounts for 0.5% to 1% of all soft tissue sarcomas. Because of its rarity, ASPS is easily misdiagnosed, increasing the risk of incorrect treatment. PATIENT CONCERNS: A 6-year-old female patient presented with a history of a 2.0 × 2.5 × 3.0-cm mass in the deep soft tissues of her right lower extremity. DIAGNOSES: Histopathological features indicated the diagnosis of ASPS. Microscopically, a diffuse arrangement of tumor cells or pseudoalveolar architectures separated by thin and well-vascularized fibrous septa were observed. Immunohistochemical staining of the tumor cells indicated positivity for transcription factor E3, myogenic determination factor 1, and periodic acid–Schiff–diastase (PAS-D) and showed a Ki-67 proliferating index of approximately 20%. INTERVENTIONS: The patient underwent enlarged resection of the tumor and was treated with radiotherapy. OUTCOMES: During the 3-year follow-up, the patient has remained in good condition, with no symptom recurrence, distant metastatic spread, or significant toxicity during or after treatment. The patient remains under regular surveillance. LESSONS: Its low incidence, lack of characteristic clinical manifestations, and atypical location often lead to ASPS misdiagnosis and subsequent incorrect treatment. Nuclear expression of transcription factor E3 is of diagnostic value for ASPS. At present, there is no consensus on the treatment for ASPS. In-depth pathological analysis is needed to better understand the characteristics of this tumor. Wolters Kluwer Health 2020-01-31 /pmc/articles/PMC7004695/ /pubmed/32000418 http://dx.doi.org/10.1097/MD.0000000000018952 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5700
Wang, Bin
Wang, Huanhuan
Wei, Jinlong
Qu, Limei
Meng, Lingbin
Xin, Ying
Jiang, Xin
Alveolar soft part sarcoma of the right calf: A case report
title Alveolar soft part sarcoma of the right calf: A case report
title_full Alveolar soft part sarcoma of the right calf: A case report
title_fullStr Alveolar soft part sarcoma of the right calf: A case report
title_full_unstemmed Alveolar soft part sarcoma of the right calf: A case report
title_short Alveolar soft part sarcoma of the right calf: A case report
title_sort alveolar soft part sarcoma of the right calf: a case report
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004695/
https://www.ncbi.nlm.nih.gov/pubmed/32000418
http://dx.doi.org/10.1097/MD.0000000000018952
work_keys_str_mv AT wangbin alveolarsoftpartsarcomaoftherightcalfacasereport
AT wanghuanhuan alveolarsoftpartsarcomaoftherightcalfacasereport
AT weijinlong alveolarsoftpartsarcomaoftherightcalfacasereport
AT qulimei alveolarsoftpartsarcomaoftherightcalfacasereport
AT menglingbin alveolarsoftpartsarcomaoftherightcalfacasereport
AT xinying alveolarsoftpartsarcomaoftherightcalfacasereport
AT jiangxin alveolarsoftpartsarcomaoftherightcalfacasereport